Submission Details
| 510(k) Number | K211561 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 20, 2021 |
| Decision Date | December 05, 2021 |
| Days to Decision | 199 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K211561 is an FDA 510(k) clearance for the INVOS PM7100 Patient Monitor, INVOS Pediatric rSO2 Sensor, INVOS Infant Regional Saturation Sensor (also referred to as OxyAlert NIRSensor), a Oximeter, Tissue Saturation (Class II — Special Controls, product code MUD), submitted by Covidien, LLC (Boulder, US). The FDA issued a Cleared decision on December 5, 2021, 199 days after receiving the submission on May 20, 2021. This device falls under the Neurology review panel. Regulated under 21 CFR 870.2700.
| 510(k) Number | K211561 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 20, 2021 |
| Decision Date | December 05, 2021 |
| Days to Decision | 199 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | MUD — Oximeter, Tissue Saturation |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2700 |